About us
Expertise
International
People
Careers
News & publications
Contact us
Home
»
News & publications
»
Latest news
News & publications
Related news & insights - Will Axtell
Penningtons Manches Cooper advises bioanalysis and toxicology laboratory Analytical Services International on acquisition by Forensic Access
Posted: 23/03/2022
The corporate team at Penningtons Manches Cooper has advised the shareholders of Analytical Services International (ASI) on the sale of the company to private equity backed Forensic Access. ASI, headquartered in London, is a leading laboratory providing services including clinical trial bioanalysis, forensic toxicology and therapeutic drug monitoring......>>
Penningtons Manches Cooper advises next generation virus diagnostic company OxDX on its spin-out from Oxford University
Posted: 18/02/2022
The corporate team at Penningtons Manches Cooper has advised OxDX on the completion of its spin-out from Oxford University and its £2.6 million pre-seed funding. The funding will be used to develop its AI-powered diagnostic technology, which will be used to improve the speed, cost and accuracy of diagnostics worldwide......>>
Corporate team advises on major cross-border life sciences transaction
Posted: 27/10/2021
The Penningtons Manches Cooper corporate team has advised the shareholders of ATDBio on its sale to NASDAQ Stockholm listed Biotage AB. The purchase price was approximately £45m on a debt free and cash free basis......>>
Penningtons Manches Cooper advises on cross-border sale of ITSM software developer
Posted: 25/08/2021
Penningtons Manches Cooper has advised on the sale of Snapbytes to Appfire, a leading US provider of software development apps. With more than 4,300 global installations of its IT Service Management (ITSM) applications, Snapbytes is the maker of the most-downloaded service-level agreement app on the Atlassian Marketplace - one of the largest enterprise software marketplaces......>>
Penningtons Manches Cooper advises biomaterials company on £4.5 million fundraising round
Posted: 17/05/2021
The corporate team at Penningtons Manches Cooper has acted for The Electrospinning Company (Electrospinning) on the completion of a £4.5 million fundraising round, its largest to date......>>
Penningtons Manches Cooper advises Oxford University spin-out aiming to develop cancer vaccines
Posted: 23/04/2021
The corporate and IP team at Penningtons Manches Cooper has advised new immuno-oncology company, OxVax, on its spin-out from Oxford University......>>
1
2
3
4
Filter news & insights
Filter by keyword:
Filter by expertise:
Select an area of expertise
Banking and finance
Cauda Equina Syndrome claims
Charities
Clinical negligence
Commercial
Company secretarial services
Construction and infrastructure
Corporate
Corporate tax
Cosmetic surgery claims
Court of Protection and deputyships
Cyber security and cyber crime
Cycle and bike accident claims
Data protection and privacy
Digital business
Education
Elderly care claims
Employee share schemes
Employment for Business
Employment for Individuals
Energy regulatory
Equity capital markets
Family law
Fashion and luxury brands
Financial services
Financial services regulation
Fintech
Funding a personal injury claim
Gender pay gap reporting
Holiday accident claims
Hospital fall claims
Housing
Housing governance
Immigration for Business
Inquest representation
Inquest representation
Intellectual property
International trade
IT and telecommunications
Life sciences
Marine, trade and energy
Ophthalmology claims
Pensions
Personal injury
Planning
Private client and tax
Product liability claims
Product liability claims
Real estate
Real estate investors
Real estate litigation
Regulatory compliance
Renewable energy and cleantech
Residential property and conveyancing
Retail
Shipping
Social housing management
Sports
Stillbirth and neonatal death claims
Surgical error claims
Technology
Technology transfer and spin-outs
Vaginal mesh claims
In this section
Latest news
Archive news
Publications
Media enquiries
Contact our press team on:
+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)